Uniunea Europeană - română - EMA (European Medicines Agency)

sandoz gmbh - infliximab - arthritis, psoriatic; psoriasis; crohn disease; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - imunosupresoare - tratamentul de artrita reumatoida, boala crohn, colita ulcerativa, spondilita anchilozantă, artrita psoriazică și psoriazis.

Uniunea Europeană - română - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - agenți antineoplazici - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

celltrion healthcare co. ltd. - infliximabum - liofilizat pentru concentrat pentru soluţie perfuzabilă - 100 mg

Uniunea Europeană - română - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - limfom, mantle-cell - protein kinazei - treatment of mantle cell lymphoma (mcl).